The invention relates to the use of INSP163 for treatment and/or prevention ofcancer and/or musculoskeletal/connective tissue disorder, in particular oflung cancer and/or osteoarthritis. Combinations of INSP163 with an interferon,a TNF antagonist or a further anti-cancer or anti-arthritis agent are alsowithin the present invention.